These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28076305)

  • 1. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
    De Sloovere MMW; De Smet D; Baert FJ; Debrabandere J; Vanpoucke HJM
    Clin Chem Lab Med; 2017 Aug; 55(9):1435-1446. PubMed ID: 28076305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
    Delefortrie Q; Schatt P; Grimmelprez A; Gohy P; Deltour D; Collard G; Vankerkhoven P
    Clin Biochem; 2016 Feb; 49(3):268-73. PubMed ID: 26506117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical Performance and Clinicopathologic Correlation of Four Fecal Calprotectin Methods.
    Pelkmans LPJ; de Groot MJM; Curvers J
    Am J Clin Pathol; 2019 Aug; 152(3):392-398. PubMed ID: 31152542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease.
    Oyaert M; Boel A; Jacobs J; Van den Bremt S; De Sloovere M; Vanpoucke H; Van Hoovels L
    Clin Chem Lab Med; 2017 Aug; 55(10):1564-1573. PubMed ID: 28222018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
    Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
    Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
    PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Analytical Verification of an Automated Fecal Calprotectin Immunoassay with Extraction Device.
    Wyness SP; Lin L; Jensen R; Bird J; Norgyal T; Jensen G; Johnson LM
    J Appl Lab Med; 2021 Jul; 6(4):931-941. PubMed ID: 33582792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A; Knol M; Kobold AM; Bootsman J; Dijkstra G; van Rheenen PF
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1742-1749.e2. PubMed ID: 28606846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.
    Noebauer B; Ramic L; Konstantin A; Zachbauer C; Einwallner E
    Biochem Med (Zagreb); 2017 Oct; 27(3):030710. PubMed ID: 29180918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ; Sydora BC; Fedorak RN
    J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V; Malmstrøm GH; Skar V; Røseth A; Moum B
    Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Next-Generation Assays for Fecal Calprotectin vs the PhiCal Assay.
    Lin L; Wyness SP; Jensen R; Bird J; Norgyal T; Jensen G; Johnson LM
    Am J Clin Pathol; 2022 Feb; 157(2):252-256. PubMed ID: 34390332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.
    Campbell JP; Zierold C; Rode AM; Blocki FA; Vaughn BP
    J Clin Gastroenterol; 2021 Mar; 55(3):239-243. PubMed ID: 32324678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel sol particle immunoassay for fecal calprotectin in inflammatory bowel disease patients.
    Okuyama Y; Doi Y; Matsuyama N; Uchino M; Yamamoto T
    Clin Chim Acta; 2016 May; 456():1-6. PubMed ID: 26908083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111.
    Mandic-Havelka A; Nilsen T; Sunde K; Norell M; Hansson LO; Larsson A
    Clin Lab; 2017 May; 63(5):907-913. PubMed ID: 28627817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.